Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nammi Therapeutics Inc
Nammi Therapeutics Inc
University Health Network, Toronto
Turning Point Therapeutics, Inc.
Verastem, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Avera McKennan Hospital & University Health Center
Indiana University
Washington University School of Medicine
Revolution Medicines, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DualityBio Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Shanghai Juncell Therapeutics
Revolution Medicines, Inc.
British Columbia Cancer Agency
Revolution Medicines, Inc.
Marengo Therapeutics, Inc.
University Health Network, Toronto
Shanghai Yunying Medical Technology